(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione

C33H42N6O6 — CID 131929142

IUPAC(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione
SMILESCOc1cc2ccc1OCC(=O)N[C@@H](C)C(=O)N(C)CCCCN(C(=O)Cn1c(C3CC3)nc3ccccc31)CCCNC2=O
InChIInChI=1S/C33H42N6O6/c1-22-33(43)37(2)16-6-7-17-38(30(41)20-39-26-10-5-4-9-25(26)36-31(39)23-11-12-23)18-8-15-34-32(42)24-13-14-27(28(19-24)44-3)45-21-29(40)35-22/h4-5,9-10,13-14,19,22-23H,6-8,11-12,15-18,20-21H2,1-3H3,(H,34,42)(H,35,40)/t22-/m0/s1
InChIKeyCKIYIIRKROPNNF-QFIPXVFZSA-N
MW618.74 g/mol
LogP2.71
Rot. Bonds4

About (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione

(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione (PubChem CID 131929142) has the molecular formula C33H42N6O6 and a molecular weight of 618.74 g/mol. Its IUPAC name is (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione.

Molecular Properties

Compound Name(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione
PubChem CID131929142
Molecular FormulaC33H42N6O6
Molecular Weight618.74 g/mol
Exact Mass618.32
IUPAC Name(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione
SMILESCOc1cc2ccc1OCC(=O)N[C@@H](C)C(=O)N(C)CCCCN(C(=O)Cn1c(C3CC3)nc3ccccc31)CCCNC2=O
InChIInChI=1S/C33H42N6O6/c1-22-33(43)37(2)16-6-7-17-38(30(41)20-39-26-10-5-4-9-25(26)36-31(39)23-11-12-23)18-8-15-34-32(42)24-13-14-27(28(19-24)44-3)45-21-29(40)35-22/h4-5,9-10,13-14,19,22-23H,6-8,11-12,15-18,20-21H2,1-3H3,(H,34,42)(H,35,40)/t22-/m0/s1
InChIKeyCKIYIIRKROPNNF-QFIPXVFZSA-N
XLogP2.71
TPSA135.10 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds4
Heavy Atoms45
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500618.74
LogP ≤ 52.71
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'crown_ether', 'substructure': 'N/A'}

Analyze (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione?
The IUPAC name of (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione (CID 131929142) is (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione.
What is the SMILES notation for (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione?
The canonical SMILES for (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione is COc1cc2ccc1OCC(=O)N[C@@H](C)C(=O)N(C)CCCCN(C(=O)Cn1c(C3CC3)nc3ccccc31)CCCNC2=O.
What is the InChIKey of (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione?
The InChIKey is CKIYIIRKROPNNF-QFIPXVFZSA-N. The full InChI is InChI=1S/C33H42N6O6/c1-22-33(43)37(2)16-6-7-17-38(30(41)20-39-26-10-5-4-9-25(26)36-31(39)23-11-12-23)18-8-15-34-32(42)24-13-14-27(28(19-24)44-3)45-21-29(40)35-22/h4-5,9-10,13-14,19,22-23H,6-8,11-12,15-18,20-21H2,1-3H3,(H,34,42)(H,35,40)/t22-/m0/s1.
What are the key properties of (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione?
(6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione has a molecular weight of 618.74 g/mol, XLogP of 2.71, 4 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for (6S)-13-[2-(2-cyclopropylbenzimidazol-1-yl)acetyl]-21-methoxy-6,8-dimethyl-2-oxa-5,8,13,17-tetrazabicyclo[17.2.2]tricosa-1(21),19,22-triene-4,7,18-trione is sourced from PubChem (CID 131929142), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).